<http://schema.org/description>
"With a year-to-date return of nearly 130%, it&amp;amp;#39;s been a good year so far for this biopharma company."^^<http://www.w3.org/2001/XMLSchema#string>
<https://www.zacks.com/commentary/22345/santarus>